Guerbet SA (EPA:GBT)
8.00
-0.06 (-0.74%)
Aug 3, 2026, 1:08 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €101.68 million as of August 3, 2026. Its market cap has decreased by -60.06% in one year.
Market Cap
101.68M
Enterprise Value
420.46M
Revenue
798.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.00
ChartMarket Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 101.68M, a decrease of -28.82%. That is a compound annual growth rate of -0.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 101.68M | -43.57% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 379.16M |
| Eurobio Scientific Société anonyme | 201.37M |
| Median Technologies | 157.81M |
| Theraclion | 42.48M |
| Novacyt | 30.92M |
| Mauna Kea Technologies | 30.28M |
| Diagnostic Medical Systems | 27.99M |
| Ikonisys | 23.76M |